MedTrace Logo

Effect of Behavioral Lifestyle Intervention on Frailty in Older Adults With Diabetes

NCT04440449 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-05-24

Study results available
· View outcomes & findings →

Summary

The study team want to see if changes in lifestyle and behaviors and self-monitoring of diet and physical activity in older adults who have type 2 Diabetes (T2D) may help to prevent or reduce frailty. Frailty occurs in older adults and leads people to have falls, become disabled, require nursing home placement, and have increased risk of death. T2D is one of the major risk factors for frailty. T2D is a significant problem in older adults and is known to increase the risk of future frailty.

Conditions

Interventions

BEHAVIORAL

Lifestyle App

A mobile app used to assist with lifestyle changes

BEHAVIORAL

Look AHEAD behavior lifestyle intervention

A modified Look AHEAD behavior lifestyle intervention with smartphone-based self-monitoring of diet and physical activity

BEHAVIORAL

Abbreviated Look AHEAD behavior lifestyle intervention

An abbreviated Look AHEAD behavior lifestyle intervention with smartphone-based self-monitoring of diet and physical activity

Sponsors & Collaborators

  • The Claude D. Pepper Older Americans Independence Centers

    collaborator OTHER

  • National Institute on Aging (NIA)

    collaborator NIH

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Rozmin Jiwani, RN, PhD · University of Texas Health at San Antonio

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-15
Primary Completion
2020-10-20
Completion
2022-04-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04440449 on ClinicalTrials.gov